
Why Finding the Right Drug Dose Is So Difficult | Dr. Ewoud-Jan van Hoogdalem
Episode 48
A drug shows promise in a small patient study. How much does that tell you about the dose you should test next? Gregory Austin and Dr. Chad Briscoe explore that question with Dr. Ewoud-Jan van Hoogdalem, a board-certified clinical pharmacologist and former Vice President of Clinical Pharmacology at ICON. He explains how first-in-human studies inform dose selection, why an early signal in patients can leave important questions unanswered, and how a dose that makes it through development can still prove difficult for patients to tolerate in everyday use. Drawing on his experience in small biotech and large pharma, Ewoud-Jan also discusses when combining study objectives makes sense and how teams decide which evidence they can afford to go without. Connect with Ewoud-Jan on LinkedIn: https://www.linkedin.com/in/ewoud-jan-van-hoogdalem-6836012/ Ewoud-Jan’s chosen charity is Doctors Without Borders (Médecins Sans Frontières). https://www.doctorswithoutborders.org/ THANK YOU TO OUR SPONSORS TruTechnologies: The industry’s first Live Clinical Trial Execution platform, helping research teams prevent errors while giving sponsors instant visibility into trial activity. https://trutechnologies.ai/ Leucentra: Inspired by science, empowered by IT. https://leucentra.com/
Publisher
BioTalk Unzipped
Link
biotalk-unzipped.captivate.fm/episode/drug-dose-selection
Published
November 5, 2026
Duration
54 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Gregory Austin
BioTalk Unzipped
@biotalkunzipped
#drugdose #difficult #janvanhoogdalem #lifesciences #medicine
